Second Sight Medical Products

$0.715
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.045 (-5.73%) Today
-$0.025 (-3.38%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell EYES and other stocks, options, and ETFs commission-free!

About EYES

Second Sight Medical Products, Inc. engages in the development, manufacture, and marketing of implantable visual prosthetics. It operates through the following geographical segments: United States, Italy, France, and China. Read More The firm's product include Argus II Retinal Prosthesis System that treats outer retinal degenerations, such as retinitis pigmentosa, also referred to as RP. The company was founded by Alfred E. Mann, Aaron Mendelsohn, Sam Williams, Robert J. Greenberg, and Gunnar Bjorg in 1998 and is headquartered in Sylmar, CA. The listed name for EYES is Second Sight Medical Products, Inc. Common Stock.

CEO
Matthew J. Pfeffer
Employees
112
Headquarters
Sylmar, California
Founded
1998
Market Cap
17.11M
Price-Earnings Ratio
Dividend Yield
Average Volume
161.37K
High Today
$0.792
Low Today
$0.7333
Open Price
$0.7842
Volume
274.20K
52 Week High
$7.60
52 Week Low
$0.6906

Collections

EYES Earnings

-$0.49
-$0.33
-$0.16
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 12, After Hours

You May Also Like